Market Tracker

04/28 5:16pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

14.05
Delayed Data
As of Apr 28
 +0.25 / +1.81%
Today’s Change
7.75
Today|||52-Week Range
35.24
+6.04%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close13.80
Today’s open13.80
Day’s range13.80 - 14.20
Volume1,483,280
Average volume (3 months)1,912,456
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-37.53%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.02+0.39%
ALDRAlder Biopharmaceuti...-1.30-6.09%
CORTCorcept Therapeutics...+0.20+2.14%
AIMTAimmune Therapeutics...-0.23-1.17%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts